Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA)

Regional University Hospital Center (CHRU)

Status: Active, not recruiting

Conditions: Alopecia Areata

Study type: Observational

Funder types: Other

Identifiers

NCT06471114

29BRC23.0239 - ESTAA

Details and patient eligibility

About

The aim of our study was to retrospectively assess the efficacy and safety of systemic treatments in patients with alopecia areata, by recruiting cases from the HUGO network (Hôpitaux Universitaires du Grand Ouest), a network of 5 hospitals : Brest, Nantes, Rennes, Angers and Tours.

Enrollment: 250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with severe alopecia
• Has received at least one systemic treatment for at least 3 months (among methotrexate, intravenous or oral corticosteroid therapy, Ciclosporin, UVA/UVB phototherapy)
• Patient affiliated to a social security scheme
• Age greater than or equal to 18 years

Exclusion criteria

• Patients under legal protection (guardianship, curatorship, etc.)
• Refusal to participate
• Other cause of alopecia
• Follow-up less than 3 months
• Age under 18 years